PAVmed Inc. (PAVM): Koefisien rega marang pendapatan

PAVmed Inc. complies with basic environmental regulations and plastic disposal standards. This chart of the capitalization-to-revenue ratio demonstrates the business valuation trend, where the indicator settled at 76.30. PAVmed Inc. effectively commercializes medical ideas through its incubator, creating a diversified product portfolio. High demand for unique esophageal cancer diagnostics provides the firm with significant pricing power.

PAVM: Rasio rega marang pendapatan PAVmed, Inc. 04.07.2022 - 13.11.2026

Rincian analitis perusahaan PAVmed Inc. (PAVM)

- nilai saham lan prakiraan konsensus rega:

Rega saham pavmed.com|PAVM - Bagan rega target

- data kapitalisasi bursa:

Kapitalisasi pasar PAVmed Inc|PAVM - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian nilai buku perusahaan:

Nilai Akuntansi Saham PAVmed|PAVM - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih pavmed.com|PAVM - Total Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

- informasi bathi lan kelipatan valuasi:

PAVM - Bathi resik perusahaan|Bathi sing dikarepake PAVmed Inc.|PAVM - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi pavmed.com|PAVM - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PAVmed Inc|PAVM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajroning taun lumaku PAVmed|PAVM - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan pavmed.com|PAVM - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep PAVmed Inc.

- data total pendapatan lan volume dodolan:

PAVM - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan pavmed.com|PAVM - Rasio rega marang pendapatan|Multiplikator forward rega marang pendapatan PAVmed Inc

Analisis umum perusahaan:PAVM, PAVmed, Inc.

To minimize risks, an investor must compare the market capitalization of PAVmed Inc. (PAVM) with actual sales volume, utilizing price/sales ratio dynamics to identify abnormal deviations of value from revenue. Amid the commercialization of the EsoGuard test, this indicator assesses the efficiency of business scaling, making it possible to determine the extent to which market expectations regarding the integration of the company's technologies into US medical standards are justified.

Perusahaan pesaing

Multiplikator P/S stryker.com (SYK)|Rasio rega marang pendapatan Medtronic MDT|Koefisien rega marang pendapatan Royal Philips (PHG)|SNN: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HOLX (Hologic Medical)|Carlisle Companies (CSL) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan integer.net|LIVN (LivaNova) - Multiplikator P/S|Rega marang dodolan AdaptHealth Corp AHCO|Multiplikator P/S SSII|Avanos Corp - Rasio kapitalisasi marang pendapatan|Multiplikator P/S SI (Shoulder Innovations)|Koefisien rega marang pendapatan viemed.com (VMD)|Inogen Medical - Multiplikator P/S|Owlet, Inc. (OWLT) - Kapitalisasi marang pendapatan|QIPT: Multiplikator P/S|Precision Optics Corporation (POCI) - Multiplikator P/S|Rasio rega marang pendapatan Tivic Health Systems|Rasio rega marang pendapatan MOVE|Kapitalisasi marang pendapatan NUVO (Nuvo Group)